BAKER-GLENN, CHARLES,BURDICK, DANIEL JON,CHAMBERS, MARK,CHEN, HUIFEN,ESTRADA, ANTHONY,SWEENEY, ZACHARY KEVIN,CHAN, BRYAN K.
申请号：
SG2013021100
公开号：
SG189043A1
申请日:
2011.11.09
申请国别(地区):
SG
年份:
2013
代理人:
摘要：
Compounds of the formula (I), or pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
